CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 764 enrolled
Drug / intervention
AN2728 Topical Ointment, 2% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02118792
NCT02118792Phase 3Completed
CompareCT.gov

A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

Pfizer·interventional·Posted Apr 21, 2014·Updated Mar 6, 2017

In Brief

A Phase 3 clinical trial evaluating AN2728 Topical Ointment, 2% and Matching vehicle control for Dermatitis, Atopic. Completed, enrolled 764 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate the safety and efficacy of AN2728 Topical Ointment, 2% in children, adolescents, and adults (ages 2 years and older) with atopic dermatitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDermatitis, Atopic
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 21, 2014
Enrollment StartMar 1, 2014
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 12.2 years ago

Interventions

AN2728 Topical Ointment, 2%drug

Matching vehicle controldrug